NMDAR2A Antikörper (PE-Cy5)
Kurzübersicht für NMDAR2A Antikörper (PE-Cy5) (ABIN747365)
Target
Alle NMDAR2A (GRIN2A) Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Verwendungszweck
- NMDAR2A Polyclonal Antibody, PE-Cy5 Conjugated
-
Kreuzreaktivität
- Human
-
Homologie
- Mouse,Rat
-
Aufreinigung
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human NMDAR2A
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- WB(1:300-5000)
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Konservierungsmittel
- ProClin
-
Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
Haltbarkeit
- 12 months
-
-
- NMDAR2A (GRIN2A) (Glutamate Receptor, Ionotropic, N-Methyl D-Aspartate 2a (GRIN2A))
-
Andere Bezeichnung
- NMDAR2A
-
Hintergrund
-
Synonyms: LKS, EPND, FESD, NR2A, GluN2A, NMDAR2A, Glutamate receptor ionotropic, NMDA 2A, Glutamate [NMDA] receptor subunit epsilon-1, N-methyl D-aspartate receptor subtype 2A, hNR2A, GRIN2A
Background: NMDA receptor subtype of glutamate-gated ion channels possesses high calcium permeability and voltage-dependent sensitivity to magnesium. Activation requires binding of agonist to both types of subunits.
-
Molekulargewicht
- 165kDa
-
Gen-ID
- 2903
-
UniProt
- Q12879
-
Pathways
- Synaptic Membrane, Regulation of long-term Neuronal Synaptic Plasticity
Target
-